Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MORN2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | STAP1 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.003 |
mRNA | EPS8 | gCSI | pan-cancer | AAC | 0.21 | 0.003 |
mRNA | ACAT2 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | CSGALNACT2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | PGBD1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | ARHGAP31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CEP55 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
mRNA | PHKG2 | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
mRNA | TRAK2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |